C.O.D.E. 2.0 Conference Highlights the Future of Diabetes Care in India

The future of diabetes care in India is moving beyond simply controlling blood sugar levels. That was one of the central messages to emerge from C.O.D.E. 2.0, the Conference on Diabetes Evolution 2.0, held in Chennai under the theme “Transforming Diabetes Care through Innovation, Integration & Impact.”

Organised by the Club for Diabetes Excellence (C.O.D.E.), the conference brought together around 750 doctors, healthcare professionals and researchers to examine the changing landscape of diabetes management. Discussions covered personalised treatment, insulin therapy, obesity and metabolic health, gestational diabetes, diabetic foot care, Type 1 diabetes, emerging therapies and the growing role of technology.

The conference comes at a time when diabetes care is becoming increasingly complex. Treating the condition is no longer limited to prescribing medication and asking patients to monitor glucose levels. Healthcare professionals are increasingly looking at the individual patient’s risks, lifestyle, complications, metabolic health and access to technology when designing a treatment strategy.

Why C.O.D.E. 2.0 Matters for India’s Diabetes Future

India’s diabetes challenge requires more than a one-size-fits-all approach. Patients can differ significantly in their age, disease duration, weight, complications, lifestyle, response to medicines and ability to monitor glucose.

Against this backdrop, the C.O.D.E. 2.0 conference placed innovation, integration and impact at the centre of discussions about the future of diabetes care.

The emphasis is important because better diabetes management is not simply about achieving a satisfactory glucose reading on a particular day. Long-term care aims to reduce the risk of complications while helping patients maintain a sustainable quality of life.

The conference’s forward-looking theme, “Diabetes 2030–2050: From Control to Cure,” reflected this broader change in thinking. It pointed towards a model in which prevention, early detection, personalised treatment and technology work together rather than functioning as separate parts of healthcare.

Diabetes Care Is Shifting From Control to Prevention

Traditional diabetes management has often focused heavily on controlling blood glucose after the disease has already developed. Modern care increasingly asks a different question: Can risks be identified and addressed earlier?

Early intervention can involve recognizing metabolic risk, addressing obesity, improving lifestyle factors, monitoring glucose more effectively and identifying complications before they become advanced.

This shift is particularly relevant to complications such as diabetic foot disease. Once a serious foot wound develops, treatment can become considerably more difficult. Early screening and preventive foot care can therefore play an important role in reducing avoidable complications.

At C.O.D.E. 2.0, Dr Vijay Viswanathan, Head and Chief Diabetologist at M.V. Hospital for Diabetes, addressed diabetic foot prevention and early intervention, highlighting an area where timely action can have significant consequences for patients.

Technology Is Becoming Part of Everyday Diabetes Management

One of the strongest themes running through modern diabetes care is the increasing use of digital technology.

The scientific programme at C.O.D.E. 2.0 included discussions on Artificial Intelligence, digital healthcare and Continuous Glucose Monitoring (CGM). These technologies have the potential to change how clinicians and patients understand glucose patterns and make treatment decisions.

CGM, for example, can provide information about glucose levels throughout the day rather than relying exclusively on individual finger-stick measurements. The additional information can help reveal patterns related to meals, physical activity, sleep, medication and other daily factors.

Artificial Intelligence could add another layer by helping analyse large volumes of health information and identify patterns that may otherwise be difficult to detect manually. However, technology is most useful when it supports clinical judgment rather than attempting to replace it.

Why Personalised Diabetes Care Is Gaining Importance

There is no single diabetes journey. Two people with apparently similar glucose levels may have very different cardiovascular risks, medication requirements, lifestyles or complications.

This is where personalised diabetes management becomes important.

Instead of treating a laboratory value in isolation, clinicians can consider a wider set of factors, including the patient’s overall metabolic health, weight, complications, treatment response and individual circumstances.

The conference’s focus on personalised care reflects this broader evolution. The objective is not simply to add more technology or medicines, but to use available information to make treatment more relevant to each patient.

From Glucose Management to Metabolic Health

Another major theme at C.O.D.E. 2.0 was the connection between diabetes, obesity and metabolic health.

Diabetes does not exist in isolation. Excess body weight, insulin resistance and other metabolic abnormalities can interact with one another and influence an individual’s long-term health risks.

Consequently, diabetes care increasingly involves looking beyond glucose alone. Weight management, nutrition, physical activity and broader metabolic health can all become part of an integrated treatment strategy.

This is a significant conceptual change. A patient may need support not only to lower blood glucose but also to address the factors contributing to metabolic dysfunction in the first place.

Insulin Therapy Remains a Key Part of the Conversation

Despite rapid advances in digital health and newer treatment approaches, insulin continues to have an important role in diabetes management.

The C.O.D.E. 2.0 scientific programme included sessions on insulin therapy, reflecting the continuing need to improve how insulin is used and integrated into patient care.

The challenge is not simply whether insulin is available. Effective treatment also depends on appropriate timing, monitoring, patient education and individualisation of therapy.

Technology such as CGM may increasingly provide clinicians and patients with better information for understanding glucose patterns, potentially supporting more informed treatment decisions.

Gestational Diabetes Requires a Different Lens

Gestational diabetes was also included in the conference programme, highlighting another important area of diabetes care.

Diabetes during pregnancy requires careful management because the health of both the mother and developing baby can be affected by uncontrolled blood glucose.

The inclusion of gestational diabetes within a broader conference on diabetes evolution is significant because it reinforces the need to view diabetes across different stages of life rather than treating it as a single condition affecting one population.

Type 1 Diabetes and the Need for Continuous Care

Type 1 diabetes presents another set of challenges. People living with Type 1 diabetes require ongoing management and monitoring, making access to appropriate treatment, education and technology particularly important.

The conference’s inclusion of Type 1 diabetes alongside Type 2 diabetes, gestational diabetes and metabolic health demonstrates the breadth of modern diabetes care.

It also underlines an important principle: innovation must translate into practical improvements for different groups of patients rather than focusing exclusively on the largest segment of the diabetes population.

Diabetic Foot Care Shows Why Early Intervention Matters

Among the many topics discussed at C.O.D.E. 2.0, diabetic foot care stands out because it illustrates the consequences of delayed intervention.

Diabetes can affect nerves and blood circulation, increasing the risk of unnoticed injuries and delayed healing. A small foot injury can therefore become a significant medical problem if it is not identified and managed promptly.

Prevention begins with awareness and regular assessment. Patients living with diabetes should understand the importance of looking after their feet and reporting unusual wounds, changes or symptoms to healthcare professionals.

For clinicians, the emphasis on early intervention reinforces a broader lesson from diabetes medicine: preventing a complication is often preferable to managing an advanced complication.

What Artificial Intelligence Could Change in Diabetes Care

Artificial Intelligence was among the emerging areas discussed during the conference. Its potential in healthcare is broad, but diabetes may be particularly suited to data-driven approaches because management can generate large amounts of information.

Glucose readings, medication schedules, dietary patterns, physical activity and other health information can create complex datasets. AI-based systems may eventually help clinicians identify trends, support risk assessment or personalise recommendations.

However, the promise of AI should be balanced with practical considerations. Healthcare professionals still need to assess whether an algorithm’s output is clinically appropriate, while patient privacy, data quality and accessibility remain important considerations.

The most useful future may not be “AI replacing doctors,” but AI helping doctors make better use of information.

Continuous Glucose Monitoring Could Make Diabetes More Visible

Traditional glucose testing provides snapshots. Continuous Glucose Monitoring can provide a much broader picture of how glucose changes over time.

That difference matters because diabetes is influenced by everyday behaviour. A patient’s glucose response can change after different meals, levels of physical activity, stress, sleep patterns or medication schedules.

With more continuous information, clinicians can potentially see patterns that isolated measurements may miss. Patients may also gain a clearer understanding of how everyday choices influence their glucose levels.

Nevertheless, technology alone cannot guarantee better outcomes. Devices need to be accessible, affordable and used correctly, while the information they generate must be translated into meaningful clinical action.

A More Integrated Model of Diabetes Care

The word “integration” in the conference theme is particularly relevant. Diabetes care increasingly involves multiple areas that were once treated separately.

The Bigger Question: Can Innovation Reach Every Patient?

Perhaps the most important question raised by the future-focused discussion is not whether new technologies will emerge. They almost certainly will.

The bigger question is how widely those innovations can be translated into everyday diabetes care.

A sophisticated monitoring device or AI-supported system has limited impact if patients cannot access it, healthcare professionals are not trained to use it, or the resulting information does not lead to better clinical decisions.

This makes implementation just as important as invention. India’s diabetes strategy will need to balance cutting-edge technology with affordable treatment, primary healthcare, patient education and strong preventive services.

In other words, the future of diabetes care may depend as much on integration and accessibility as on scientific breakthroughs.

What Diabetes Care Could Look Like by 2030 and Beyond

The “Diabetes 2030–2050” theme provides a useful framework for thinking about where the field could be heading.

Future diabetes care is likely to become increasingly data-driven and personalised. Instead of waiting for complications to appear, healthcare systems can place greater emphasis on risk identification and early intervention.

Patients may also become more active participants in their care as digital tools provide more information about their own health patterns.

At the same time, doctors will remain central to interpreting that information, identifying clinical priorities and adapting treatment to the patient’s circumstances.

The likely direction is therefore not a technology-only healthcare model, but a partnership between clinicians, patients and digital tools.

Conclusion: C.O.D.E. 2.0 Points to a More Personalised Diabetes Future

C.O.D.E. 2.0 in Chennai brought together around 750 healthcare professionals, doctors and researchers to examine how diabetes care could evolve in the coming decades.

The conference highlighted a clear shift from conventional disease control towards a broader model built around personalisation, prevention, early intervention, technology and integrated metabolic care.

Discussions around insulin therapy, obesity, gestational diabetes, Type 1 diabetes, diabetic foot care, emerging treatments, Artificial Intelligence, digital healthcare and Continuous Glucose Monitoring show how wide the field of diabetes care has become.

The central lesson is perhaps the simplest: innovation matters most when it improves real patient outcomes. As India prepares for the next phase of its diabetes challenge, the combination of clinical expertise, early intervention, responsible technology and accessible care could prove more important than any single new device or treatment.

C.O.D.E. 2.0 therefore represents more than a discussion about future technology. It reflects a broader transformation in how diabetes itself is being understood—from a condition to be controlled to a long-term health challenge that requires earlier action, smarter care and a more personalised approach.